U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07602517) titled 'Guselkumab for Overlap Inflammatory Bowel Disease and Spondyloarthritis' on May 15.
Brief Summary: This is an observational study of a prospective cohort of guselkumab-initiating Crohn's Disease (CD) and Ulcerative Colitis (UC) patients to identify new or incident spondyloarthritis. This study will include adult patients aged 18-75 with IBD who are undergoing guselkumab intravenous or subcutaneous induction over a 1-year timeframe.
Study Start Date: May 20
Study Type: OBSERVATIONAL
Condition:
Spondyloarthritis
Inflammatory Bowel Diseases
Intervention:
DRUG: Guselkumab
Guselkumab intravenous or subcutaneous induction.
Recruitm...